SOLIGENIX, INC. Increase (Decrease) in Inventories
SOLIGENIX, INC. (SNGX) reported Increase (Decrease) in Inventories of $0 for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2012-03-27
- SOLIGENIX, INC. increase (decrease) in inventories for the quarter ending 2011-12-31 was $0.00.
- SOLIGENIX, INC. increase (decrease) in inventories for the quarter ending 2011-09-30 was $0.00.
- SOLIGENIX, INC. increase (decrease) in inventories for the quarter ending 2010-12-31 was $0.00.
- SOLIGENIX, INC. increase (decrease) in inventories for the quarter ending 2010-09-30 was -$35.13K.
- SOLIGENIX, INC. increase (decrease) in inventories for fiscal 2011 was $0.00.
- SOLIGENIX, INC. increase (decrease) in inventories for fiscal 2010 was -$42.87K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27 | $0.00 derived: sum of 2 quarters · filed 2012-03-27 | $0.00 10-K · filed 2012-03-27 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | ||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-12 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27 | -$35.13K derived: sum of 2 quarters · filed 2012-03-27 | -$42.87K 10-K · filed 2012-03-27 | |
| 2010-09-30 | -$35.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$42.87K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | -$7.73K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |